Influenza Vaccine

Influenza Vaccine Clinical Trials

Join Our Clinical Trial for a New Seasonal Flu Vaccine!

What is This Study About?

We are conducting a clinical trial to test a new seasonal flu vaccine. This study will compare the safety, effectiveness, and immune response of our new vaccine with a standard, approved inactivated flu vaccine. We are looking for adults aged 50 and older to participate.

Why is This Important?

Seasonal flu is a serious public health issue. The World Health Organisation estimates that flu viruses cause 3 to 5 million cases of severe illness and up to 650,000 deaths every year. By participating in this study, you can help us in the fight against the flu and contribute to the development of better vaccines.

Benefits of Participating:

  1. Reduced Risk of Flu: If you receive the study vaccine, you might be less likely to catch the flu or have serious complications if you do.
  2. Health Insights: You’ll get detailed information about your health through medical check-ups and assessments, including physical exams and vital sign measurements.
  3. Support Public Health: Your participation will aid in creating a new preventative measure for flu, potentially benefiting millions of people in the future.

Who Can Participate?

  • Adults aged 50 years or older.

Who Cannot Participate?

  • Those who are currently very ill.
  • Those who have had close contact with someone who has the flu.
  • Individuals with a history of immune system issues, frequent severe infections, or lack of a spleen.
  • Individuals with a history of severe allergic reactions or anaphylaxis.
  • Those who have had surgery within 7 days before starting the trial.

If you meet the criteria and are interested in contributing to important flu vaccine research, please consider joining our study. Your participation could make a significant difference in public health efforts against seasonal influenza.

Eligibility Checker:

By clicking submit, you are confirming that you have read & understood the Privacy Policy